The Detection of Vascular Endothelial Growth Factor in Serum of Patients with Hemorrhagic Fever with Renal Syndrome

被引:9
|
作者
Li, Man [1 ]
Ji, Yuqiang [2 ]
Dong, Yanying [1 ]
Zhou, Yan [1 ]
Ren, Huixun [1 ]
Xie, Ming [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Immunol & Pathogen Biol, Sch Med, Xian 710061, Peoples R China
[2] First Hosp Xian, Dept Cardiol, Xian, Peoples R China
关键词
Hantaan virus; VEGF; HFRS; kidney damage; HANTAVIRUS PULMONARY SYNDROME; VE-CADHERIN; CELL PERMEABILITY; VIRUS-INFECTION; DISEASE; ANGIOGENESIS; BETA; PATHOGENESIS; PUUMALA; BARRIER;
D O I
10.1007/s10753-013-9627-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hemorrhagic fever with renal syndrome (HFRS) is an acute infectious disease characterized by endothelial cell dysfunction, which results in plasma exosmosis, hyperpermeability, and sometimes hemorrhages. As one of the vascular permeability cytokines, vascular endothelial growth factor (VEGF) might mediate the hyperpermeability caused by HFRS. In the present study, the levels of serum VEGF were measured by competitive inhibition ELISA. We found variable but persistently elevated levels of VEGF throughout the various stages and types of HFRS disease, which suggested that the levels of VEGF were closely correlated to the progression of HFRS. Moreover, elevated levels of VEGF have correlation with the severity and degree of kidney damage. Therefore, to study the relationship between levels of VEGF and disease severity of patients with HFRS is helpful to clarify the pathogenesis of HFRS.
引用
收藏
页码:962 / 967
页数:6
相关论文
共 50 条
  • [21] Sustained High Level of Serum VEGF at Convalescent Stage Contributes to the Renal Recovery after HTNV Infection in Patients with Hemorrhagic Fever with Renal Syndrome
    Ma, Ying
    Liu, Bei
    Yuan, Bin
    Wang, Jiuping
    Yu, Haitao
    Zhang, Yun
    Xu, Zhuwei
    Zhang, Yusi
    Yi, Jing
    Zhang, Chunmei
    Zhou, Xingchun
    Yang, Angang
    Zhuang, Ran
    Jin, Boquan
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [22] The detection of sLFA-3 in plasma of patients with hemorrhagic fever with renal syndrome
    Xie, Ming
    Chen, Ping
    He, Lin-jing
    Qi, Bao-tai
    Wang, Ping
    Wang, Xiao-fang
    Ren, Hui-xun
    CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 9 (01) : 67 - 71
  • [23] Alterations in choroidal vascular structures due to serum levels of vascular endothelial growth factor in patients with POEMS syndrome
    Yokouchi, Hirotaka
    Nagasato, Daisuke
    Mitamura, Yoshinori
    Egawa, Mariko
    Tabuchi, Hitoshi
    Misawa, Sonoko
    Kuwabara, Satoshi
    Baba, Takayuki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
    Schips, Luigi
    Dalpiaz, Orietta
    Lipsky, Katja
    Langner, Cord
    Rehak, Peter
    Puerstner, Peter
    Pummer, Karl
    Zigeuner, Richard
    EUROPEAN UROLOGY, 2007, 51 (01) : 168 - 174
  • [25] Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis
    Jinnin, M.
    Makino, T.
    Kajihara, I.
    Honda, N.
    Makino, K.
    Ogata, A.
    Ihn, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (04) : 751 - 758
  • [26] Hemorrhagic Fever with Renal Syndrome
    Kim, Hyo Youl
    INFECTION AND CHEMOTHERAPY, 2009, 41 (06) : 323 - 332
  • [27] Serum vascular endothelial growth factor: a prognostic factor in cervical cancer
    Petra L. M. Zusterzeel
    Paul N. Span
    Marja G. K. Dijksterhuis
    Chris M. G. Thomas
    Fred C. G. J. Sweep
    Leon F. A. G. Massuger
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 283 - 290
  • [28] Serum vascular endothelial growth factor: a prognostic factor in cervical cancer
    Zusterzeel, Petra L. M.
    Span, Paul N.
    Dijksterhuis, Marja G. K.
    Thomas, Chris M. G.
    Sweep, Fred C. G. J.
    Massuger, Leon F. A. G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (02) : 283 - 290
  • [29] Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer
    Sawada, Mayumi
    Oishi, Tetsuro
    Komatsu, Hiroaki
    Sato, Shinya
    Chikumi, Jun
    Nonaka, Michiko
    Kudoh, Akiko
    Osaku, Daiken
    Harada, Tasuku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (12) : 1612 - 1619
  • [30] Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer
    Mayumi Sawada
    Tetsuro Oishi
    Hiroaki Komatsu
    Shinya Sato
    Jun Chikumi
    Michiko Nonaka
    Akiko Kudoh
    Daiken Osaku
    Tasuku Harada
    International Journal of Clinical Oncology, 2019, 24 : 1612 - 1619